Form 4: CME Group Director Sells Shares

CME Group Chairman and CEO Terrence A. Duffy reported the sale of common stock valued at over $10 million.

Summary

• Terrence A. Duffy, Chairman and CEO of CME Group Inc., reported transactions involving the sale of CME Group common stock.
• The sales occurred on May 15, 2026.
• A total of 35,000 shares were sold.
• The weighted average sale price for a portion of the shares was $298.14, and for another portion was $299.58.
• These transactions resulted in a decrease in Duffy's directly held shares.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the significant sale of shares by a key executive, which could be perceived as a lack of confidence, despite the possibility of personal financial planning.

Negatives

• Terrence A. Duffy, Chairman and CEO, sold a significant number of shares (35,000) in CME Group.
• The total value of the shares sold is approximately $10.4 million, based on the reported weighted average prices.

Future Outlook

This filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance.

Management Comments

• The filing includes a Power of Attorney document where Terrence A. Duffy grants authority to specific individuals to act on his behalf for SEC filings.
• The Power of Attorney states that it does not relieve the undersigned from responsibility for compliance with the Exchange Act, including reporting requirements under Section 16.

Industry Context

StockSavvy.ai notes that insider selling, particularly by high-ranking executives like a Chairman and CEO, can sometimes be interpreted by the market as a signal of reduced confidence, although it can also be for personal financial planning reasons.

Stakeholder Impact

• Shareholders may view the sale of a large number of shares by the Chairman and CEO with concern, potentially impacting share price sentiment.
• Employees may also be sensitive to signals from executive leadership regarding the company's future prospects.

Key Dates

Recommendation

The filing reports a significant sale of stock by a key executive, which can be a negative signal. However, without further context on the reasons for the sale or the company's overall financial performance, a 'hold' recommendation is prudent, suggesting investors monitor further developments.

Keywords

CME Group, Terrence A. Duffy, Form 4, Insider Trading, Stock Sale, Securities Exchange Act, Beneficial Ownership